|Articles|November 15, 2013

How to Implement an ePRO Strategy

How to Implement an ePRO Strategy — FREE Best Practices Guide

Four distinguished patient reported outcome (PRO) experts from major pharma have collaborated to describe how companies can best leverage the efficiencies of an ePRO strategy.

Read the eBook now.

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Trending on PharmExec

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

How to Implement an ePRO Strategy

Related Content

Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals

Insilico Medicine and CMS Enter $177 Million AI-Powered Drug Discovery Collaboration

Evogene Announces AI-Powered Small Molecule Discovery Focused Partnership with Blavatnik Center for Drug Discovery at Tel Aviv University

“AI as Reinvention”: Transforming the Business of Medicine

Utilizing 100-Percent Domestic Additive Manufacturing: Q&A with Kyle Smith

Trending on PharmExec

Pharma M&A Roundup: AstraZeneca Enters License Deal with Dizal Pharmaceutical, Chai Discovery Enters Collaboration with Novartis, Innovent Biologics Enters License Agreement with Spero Therapeutics

Nuvation Bio’s Approach to Building a Compelling Narrative

FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease

Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform

Educating Patients About GLP-1s: Q&A with Kristen Hartzell, PharmD